UBS AM’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,610
Closed -$124K 2642
2023
Q2
$124K Hold
12,610
﹤0.01% 2622
2023
Q1
$124K Hold
12,610
﹤0.01% 2622
2022
Q4
$236K Sell
12,610
-1,389
-10% -$26K ﹤0.01% 2402
2022
Q3
$290K Sell
13,999
-3,752
-21% -$77.7K ﹤0.01% 2501
2022
Q2
$369K Buy
17,751
+4,161
+31% +$86.4K ﹤0.01% 2399
2022
Q1
$585K Hold
13,590
﹤0.01% 2404
2021
Q4
$814K Buy
13,590
+499
+4% +$29.9K ﹤0.01% 2317
2021
Q3
$1.12M Sell
13,091
-152
-1% -$13.1K ﹤0.01% 2100
2021
Q2
$1.47M Sell
13,243
-1,300
-9% -$145K ﹤0.01% 1994
2021
Q1
$1.62M Sell
14,543
-1,625
-10% -$181K ﹤0.01% 1846
2020
Q4
$1.72M Buy
16,168
+252
+2% +$26.8K ﹤0.01% 1748
2020
Q3
$2.22M Buy
15,916
+3,768
+31% +$525K ﹤0.01% 1510
2020
Q2
$3.93M Buy
+12,148
New +$3.93M ﹤0.01% 1222
2019
Q4
Sell
-6,820
Closed -$168K 2681
2019
Q3
$168K Buy
6,820
+675
+11% +$16.6K ﹤0.01% 2607
2019
Q2
$217K Hold
6,145
﹤0.01% 2516
2019
Q1
$275K Buy
6,145
+858
+16% +$38.4K ﹤0.01% 2350
2018
Q4
$254K Hold
5,287
﹤0.01% 2286
2018
Q3
$353K Hold
5,287
﹤0.01% 2230
2018
Q2
$249K Buy
5,287
+2,008
+61% +$94.5K ﹤0.01% 2379
2018
Q1
$185K Buy
3,279
+1,068
+48% +$60.4K ﹤0.01% 2395
2017
Q4
$110K Hold
2,211
﹤0.01% 2392
2017
Q3
$168K Buy
2,211
+68
+3% +$5.17K ﹤0.01% 2296
2017
Q2
$202K Buy
2,143
+8
+0.4% +$752 ﹤0.01% 2222
2017
Q1
$170K Hold
2,135
﹤0.01% 2231
2016
Q4
$178K Sell
2,135
-457
-18% -$38.1K ﹤0.01% 2152
2016
Q3
$290K Hold
2,592
﹤0.01% 2288
2016
Q2
$287K Hold
2,592
﹤0.01% 2245
2016
Q1
$271K Hold
2,592
﹤0.01% 2263
2015
Q4
$209K Buy
2,592
+800
+45% +$64.5K ﹤0.01% 2514
2015
Q3
$124K Sell
1,792
-933
-34% -$64.6K ﹤0.01% 2581
2015
Q2
$267K Buy
2,725
+625
+30% +$61.2K ﹤0.01% 2435
2015
Q1
$206K Buy
2,100
+142
+7% +$13.9K ﹤0.01% 2471
2014
Q4
$216K Buy
+1,958
New +$216K ﹤0.01% 2436